reglab/housing_qa huggingface dataset:
RI Gen L § 21-28.6-17 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.6 - The Edward O. Hawkins and Thomas C. Slater Medical Marijuana Act|Section 21-28.6-17 - Revenue.

§ 21-28.6-17. Revenue.(a) Effective July 1, 2016, all fees collected by the departments of health and business regulation from applicants, registered patients, primary caregivers, authorized purchasers, licensed medical marijuana cultivators, cooperative cultivations, compassion centers, other licensees licensed pursuant to this chapter, and compassion-center and other registry identification cardholders shall be placed in restricted-receipt accounts to support the state's medical marijuana program, including but not limited to, payment of expenses incurred by the departments of health and business regulation for the administration of the program. The restricted-receipt account will be known as the "medical marijuana licensing account" and will be housed within the budgets of the departments of business regulation and health.(b) All revenues remaining in the restricted-receipt accounts after payments specified in subsection (a) of this section shall first be paid to cover any existing deficit in the department of health's restricted-receipt account or the department of business regulation's restricted-receipt account. These transfers shall be made annually on the last business day of the fiscal year.(c) All revenues remaining in the restricted-receipt accounts after payments specified in subsections (a) and (b) shall be paid into the state's general fund. These payments shall be made annually on the last business day of the fiscal year.History of Section.P.L. 2016, ch. 142, art. 14, § 2; P.L. 2017, ch. 302, art. 7, § 1; P.L. 2019, ch. 88, art. 15, § 5.
RI Gen L § 21-28.6-18 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.6 - The Edward O. Hawkins and Thomas C. Slater Medical Marijuana Act|Section 21-28.6-18 - Activities not exempt.

§ 21-28.6-18. Activities not exempt.The provisions of this chapter do not exempt any person from arrest, civil or criminal penalty, seizure or forfeiture of assets, discipline by any state or local licensing board or authority, and state prosecution for, nor may they establish an affirmative defense based on this chapter to charges arising from, any of the following acts:(1) Driving, operating, or being in actual physical control of a vehicle or a vessel under power or sail while impaired by marijuana or marijuana products;(2) Possessing or using marijuana or marijuana products if the person is a prisoner;(3) Possessing or using marijuana or marijuana products in any local detention facility, county jail, state prison, reformatory, or other correctional facility, including, without limitation, any facility for the detention of juvenile offenders; or(4) Manufacturing or processing of marijuana products with the use of prohibited solvents, in violation of this chapter; or(5) Possessing, using, distributing, cultivating, processing or manufacturing marijuana or marijuana products which do not satisfy the requirements of this chapter.History of Section.P.L. 2019, ch. 88, art. 15, § 6.
RI Gen L § 21-28.7-1 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.7 - Possession and Trafficking in Dextromethorphan|Section 21-28.7-1 - Possession of dextromethorphan.

§ 21-28.7-1. Possession of dextromethorphan.(a) No person may possess one gram or more of pure dextromethorphan or dextromethorphan as defined in accordance with U.S. pharmacopeia reference standards extracted from solid or liquid dose forms, other than a medical facility, medical practitioner, pharmacist or pharmacy licensed pursuant to title 5 of the general laws, and registrants under § 510 of the Federal Food, Drug, and Cosmetic Act pursuant to 21 U.S.C. § 321 et seq.(b) A violation of this section shall carry a civil penalty of one thousand dollars ($1,000) for the first offense, and two thousand five hundred dollars ($2,500) for the second and subsequent offenses.History of Section.P.L. 2009, ch. 215, § 1.
RI Gen L § 21-28.8-1 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.8 - The Good Samaritan Overdose Prevention Act|Section 21-28.8-1 - Expired.

§ 21-28.8-1. Expired.History of Section.P.L. 2012, ch. 251, § 1; P.L. 2012, ch. 263, § 1.
RI Gen L § 21-28.8-2 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.8 - The Good Samaritan Overdose Prevention Act|Section 21-28.8-2 - Expired.

§ 21-28.8-2. Expired.History of Section.P.L. 2012, ch. 251, § 1; P.L. 2012, ch. 263, § 1.
RI Gen L § 21-28.8-3 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.8 - The Good Samaritan Overdose Prevention Act|Section 21-28.8-3 - Expired.

§ 21-28.8-3. Expired.History of Section.P.L. 2012, ch. 251, § 1; P.L. 2012, ch. 263, § 1.
RI Gen L § 21-28.8-4 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.8 - The Good Samaritan Overdose Prevention Act|Section 21-28.8-4 - Expired.

§ 21-28.8-4. Expired.History of Section.P.L. 2012, ch. 251, § 1; P.L. 2012, ch. 263, § 1.
RI Gen L § 21-28.8-5 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.8 - The Good Samaritan Overdose Prevention Act|Section 21-28.8-5 - Expired.

§ 21-28.8-5. Expired.History of Section.P.L. 2012, ch. 251, § 1; P.L. 2012, ch. 263, § 1.
RI Gen L § 21-28.9-1 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.9 - The Good Samaritan Overdose Prevention Act of 2016|Section 21-28.9-1 - Short title.

§ 21-28.9-1. Short title.This chapter shall be known and may be cited as "The Good Samaritan Overdose Prevention Act of 2016."History of Section.P.L. 2016, ch. 1, § 1; P.L. 2016, ch. 2, § 1.
RI Gen L § 21-28.9-2 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.9 - The Good Samaritan Overdose Prevention Act of 2016|Section 21-28.9-2 - Definition.

§ 21-28.9-2. Definition."Opioid antagonist" means a drug which is a competitive antagonist that binds to the opioid receptors with higher affinity than agonists but does not activate the receptors, effectively blocking the receptor, preventing the human body from making use of opiates and endorphins.History of Section.P.L. 2016, ch. 1, § 1; P.L. 2016, ch. 2, § 1.
RI Gen L § 21-28.9-3 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.9 - The Good Samaritan Overdose Prevention Act of 2016|Section 21-28.9-3 - Authority to administer opioid antagonists - Release from liability.

§ 21-28.9-3. Authority to administer opioid antagonists — Release from liability.(a) A person may administer an opioid antagonist to another person if:(1) They, in good faith, believe the other person is experiencing a drug overdose; and(2) They act with reasonable care in administering the drug to the other person.(b) Any person, including law enforcement personnel and emergency medical personnel, who administers an opioid antagonist to another person pursuant to this section shall not be subject to civil liability or criminal prosecution as a result of the administration of the drug.(c) (1) State and municipal law enforcement personnel and emergency medical personnel to include, but not limited to, emergency medical technicians (EMTs), paramedics, and fire department personnel may provide and transfer an opioid antagonist to an individual or to his or her responsible family member, friend, or other person, along with instructions on administration and use of the opioid antagonist, to provide opioid overdose protection to the individual, in the good-faith judgment of the law enforcement or emergency medical personnel, who is at substantial risk of experiencing an opioid-related overdose event. Law enforcement and emergency medical personnel may exercise their good-faith judgment based on their experience, training, knowledge, observations, and information provided by the individual at substantial risk of experiencing an opioid-related overdose event or from the individual's family, friend, or others with knowledge of the individual's prior opioid use.(2) State and municipal law enforcement personnel and emergency medical personnel acting in good faith shall not, as a result of acts or omission in providing services in accordance with subsection (c), be liable for civil damages, unless the acts or omission constitute willful and wanton misconduct.(d) Law enforcement officers or agencies participating in the HOPE (Heroin-Opioid Prevention Effort) initiative or program and acting in good faith shall not, as the result of acts or omissions in providing services, be subject to civil liability or criminal prosecution unless the acts or omissions constitute willful and wanton misconduct.History of Section.P.L. 2016, ch. 1, § 1; P.L. 2016, ch. 2, § 1; P.L. 2018, ch. 184, § 1; P.L. 2018, ch. 288, § 1; P.L. 2019, ch. 194, § 1; P.L. 2019, ch. 250, § 1.
RI Gen L § 21-28.9-3.1 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.9 - The Good Samaritan Overdose Prevention Act of 2016|Section 21-28.9-3.1 - Narcotic testing product.

§ 21-28.9-3.1. Narcotic testing product.(a) Any person may provide, administer, or utilize a narcotic testing product to assist another person in determining whether a narcotic or substance contains chemicals, toxic substances, or hazardous compounds. Narcotic testing products shall include, but not be limited to, fentanyl test strips.(b) A person who provides, administers, or utilizes a narcotic testing product to assist another person shall not be subject to civil liability or criminal prosecution as a result of providing, administering, or utilizing the narcotic testing product to assist another person.History of Section.P.L. 2018, ch. 275, § 1.
RI Gen L § 21-28.9-4 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.9 - The Good Samaritan Overdose Prevention Act of 2016|Section 21-28.9-4 - Emergency overdose care - Immunity from legal repercussions.

§ 21-28.9-4. Emergency overdose care — Immunity from legal repercussions.(a) Any person who, in good faith, without malice and in the absence of evidence of an intent to defraud, seeks medical assistance for someone experiencing a drug or alcohol overdose or other drug- or alcohol-related medical emergency shall not be charged or prosecuted for any crime related to the possession of a controlled substance or drug paraphernalia, or the operation of a drug-involved premises, if the evidence for the charge was gained as a result of the seeking of medical assistance.(b) A person who experiences a drug or alcohol overdose or other drug- or alcohol-related medical emergency and is in need of medical assistance shall not be charged or prosecuted for any crime related to the possession of a controlled substance or drug paraphernalia, possession or transportation of alcohol by an underage person, or the operation of a drug-involved premises, if the evidence for the charge was gained as a result of the overdose and the need for medical assistance.(c) The act of providing first aid or other medical assistance to someone who is experiencing a drug or alcohol overdose or other drug- or alcohol-related medical emergency may be used as a mitigating factor in a criminal prosecution pursuant to the controlled substances act.(d) The immunity related to the possession of a controlled substance or drug paraphernalia, possession or transportation of alcohol by an underage person, or the operation of a drug-involved premises afforded under this section shall also extend to a violation of probation and/or parole on those grounds.History of Section.P.L. 2016, ch. 1, § 1; P.L. 2016, ch. 2, § 1; P.L. 2018, ch. 138, § 1; P.L. 2018, ch. 195, § 1.
RI Gen L § 21-28.9-5 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.9 - The Good Samaritan Overdose Prevention Act of 2016|Section 21-28.9-5 - Law enforcement reports.

§ 21-28.9-5. Law enforcement reports.In the first week of January, 2017, and each year thereafter, the attorney general shall, in cooperation with local law enforcement agencies and the state police, submit to the general assembly a report summarizing the impact of this chapter on law enforcement. The report shall include any incidents in which a law enforcement agency was barred, due to the immunity provisions of § 21-28.9-4, from charging or prosecuting a person under chapters 28 and 28.5 of this title, and under § 3-8-9 or § 3-8-10, who would have otherwise been so charged or prosecuted, and indicating whether the person was charged with, or prosecuted for, any other criminal offense resulting from the agency's response to the request for medical assistance.History of Section.P.L. 2016, ch. 1, § 1; P.L. 2016, ch. 2, § 1; P.L. 2018, ch. 138, § 1; P.L. 2018, ch. 195, § 1.
RI Gen L § 21-28.10-1 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.10 - Opioid Stewardship Act|Section 21-28.10-1 - Definitions.

§ 21-28.10-1. Definitions.Unless the context otherwise requires, the following terms shall be construed in this chapter to have the following meanings:(1) "Department" means the Rhode Island department of health.(2) "Director" means the director of the Rhode Island department of health.(3) "Distribute" means distribute as defined in § 21-28-1.02.(4) "Distributor" means distributor as defined in § 21-28-1.02.(5) "Manufacture" means manufacture as defined in § 21-28-1.02.(6) "Manufacturer" means manufacturer as defined in § 21-28-1.02.(7) "Market share" means the total opioid stewardship fund amount measured as a percentage of each manufacturer's, distributor's and wholesaler's gross, in-state opioid sales in dollars from the previous calendar year as reported to the U.S. Drug Enforcement Administration (DEA) on its Automation of Reports and Consolidated Orders System (ARCOS) report.(8) "Wholesaler" means wholesaler as defined in § 21-28-1.02.History of Section.P.L. 2019, ch. 88, art. 13, § 17.
RI Gen L § 21-28.10-2 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.10 - Opioid Stewardship Act|Section 21-28.10-2 - Opioid registration fee imposed on manufacturers, distributors, and wholesalers.

§ 21-28.10-2. Opioid registration fee imposed on manufacturers, distributors, and wholesalers.All manufacturers, distributors, and wholesalers licensed or registered under this title or chapter 19.1 of title 5 (hereinafter referred to as "licensees"), that manufacture or distribute opioids shall be required to pay an opioid registration fee. On an annual basis, the director shall certify the amount of all revenues collected from opioid registration fees and any penalties imposed, to the general treasurer. The amount of revenues so certified shall be deposited annually into the opioid stewardship fund restricted receipt account established pursuant to § 21-28.10-10.History of Section.P.L. 2019, ch. 88, art. 13, § 17.
RI Gen L § 21-28.10-3 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.10 - Opioid Stewardship Act|Section 21-28.10-3 - Determination of market share and registration fee.

§ 21-28.10-3. Determination of market share and registration fee.(1) The total opioid stewardship fund amount shall be five million dollars ($5,000,000) annually, subject to downward adjustments pursuant to § 21-28.10-7.(2) Each manufacturer's, distributor's, and wholesaler's annual opioid registration fee shall be based on that licensee's in-state market share.(3) The following sales will not be included when determining a manufacturer's, distributor's, or wholesaler's market share:(i) The gross, in-state opioid sales attributed to the sale of buprenorphine or methadone;(ii) The gross, in-state opioid sales sold or distributed directly to opioid treatment programs, data-waivered practitioners, or hospice providers licensed pursuant to chapter 17 of title 23;(iii) Any sales from those opioids manufactured in Rhode Island, but whose final point of delivery or sale is outside of Rhode Island;(iv) Any sales of anesthesia or epidurals as defined in regulation by the department; and(v) Any in-state intracompany transfers of opioids between any division, affiliate, subsidiary, parent, or other entity under complete and common ownership and control.(4) The department shall provide to the licensee, in writing, on or before October 15, 2019, the licensee's market share for the 2018 calendar year. Thereafter, the department shall notify the licensee, in writing, on or before October 15 of each year, of its market share for the prior calendar year based on the opioids sold or distributed for the prior calendar year.History of Section.P.L. 2019, ch. 88, art. 13, § 17.
RI Gen L § 21-28.10-4 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.10 - Opioid Stewardship Act|Section 21-28.10-4 - Reports and records.

§ 21-28.10-4. Reports and records.(a) Each manufacturer, distributor, and wholesaler licensed to manufacture or distribute opioids in the state of Rhode Island shall provide to the director a report detailing all opioids sold or distributed by that manufacturer or distributor in the state of Rhode Island. Such report shall include:(1) The manufacturer's, distributor's, or wholesaler's name, address, phone number, DEA registration number, and controlled substance license number issued by the department;(2) The name, address, and DEA registration number of the entity to whom the opioid was sold or distributed;(3) The date of the sale or distribution of the opioids;(4) The gross receipt total, in dollars, of all opioids sold or distributed;(5) The name and National Drug Code of the opioids sold or distributed;(6) The number of containers and the strength and metric quantity of controlled substance in each container of the opioids sold or distributed; and(7) Any other elements as deemed necessary or advisable by the director.(b) Initial and future reports. This information shall be reported annually to the department via ARCOS or in such other form as defined or approved by the director; provided, however, that the initial report provided pursuant to subsection (a) shall consist of all opioids sold or distributed in the state of Rhode Island for the 2018 calendar year, and shall be submitted by September 1, 2019. Subsequent annual reports shall be submitted by April 15 of each year based on the actual opioid sales and distributions of the prior calendar year.History of Section.P.L. 2019, ch. 88, art. 13, § 17.
RI Gen L § 21-28.10-5 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.10 - Opioid Stewardship Act|Section 21-28.10-5 - Payment of market share.

§ 21-28.10-5. Payment of market share.The licensee shall make payments annually to the department with the first payment of its market share due on December 31, 2019; provided, that the amount due on December 31, 2019, shall be for the full amount of the payment for the 2018 calendar year, with subsequent payments to be due and owing on the last day of every year thereafter.History of Section.P.L. 2019, ch. 88, art. 13, § 17.
RI Gen L § 21-28.10-6 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.10 - Opioid Stewardship Act|Section 21-28.10-6 - Rebate of market share.

§ 21-28.10-6. Rebate of market share.In any year for which the director determines that a licensee failed to report information required by this chapter, those licensees complying with this chapter shall receive a reduced assessment of their market share in the following year equal to the amount in excess of any overpayment in the prior payment period.History of Section.P.L. 2019, ch. 88, art. 13, § 17.
RI Gen L § 21-28.10-7 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.10 - Opioid Stewardship Act|Section 21-28.10-7 - Licensee opportunity to appeal.

§ 21-28.10-7. Licensee opportunity to appeal.(a) A licensee shall be afforded an opportunity to submit information to the department documenting or evidencing that the market share provided to the licensee (or amounts paid thereunder), pursuant to § 21-28.10-3(4), is in error or otherwise not warranted. The department may consider and examine such additional information that it determines to be reasonably related to resolving the calculation of a licensee's market share, which may require the licensee to provide additional materials to the department. If the department determines thereafter that all or a portion of such market share, as determined by the director pursuant to § 21-28.10-3(4), is not warranted, the department may:(1) Adjust the market share;(2) Adjust the assessment of the market share in the following year equal to the amount in excess of any overpayment in the prior payment period; or(3) Refund amounts paid in error.(b) Any person aggrieved by a decision of the department relating to the calculation of market share may appeal that decision to the superior court, which shall have power to review such decision, and the process by which such decision was made, as prescribed in chapter 35 of title 42.(c) A licensee shall also have the ability to appeal its assessed opioid registration fee if the assessed fee amount exceeds the amount of profit the licensee obtains through sales in the state of products described in § 21-28.10-3. The department may, exercising discretion as it deems appropriate, waive or decrease fees as assessed pursuant to § 21-28.10-3 if a licensee can demonstrate that the correctly assessed payment will pose undue hardship to the licensee's continued activities in state. The department shall be allowed to request, and the licensee shall furnish to the department, any information or supporting documentation validating the licensee's request for waiver or reduction under this subsection. Fees waived under this section shall not be reapportioned to other licensees which have payments due under this chapter.History of Section.P.L. 2019, ch. 88, art. 13, § 17.
RI Gen L § 21-28.10-8 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.10 - Opioid Stewardship Act|Section 21-28.10-8 - Departmental annual reporting.

§ 21-28.10-8. Departmental annual reporting.By January of each calendar year, the department of behavioral healthcare, developmental disabilities and hospitals (BHDDH), the executive office of health and human services (EOHHS), the department of children, youth and families (DCYF), the Rhode Island department of education (RIDE), the Rhode Island office of veterans services, the department of corrections (DOC), the department of labor and training (DLT), and any other department or agency receiving opioid stewardship funds shall report annually to the governor, the speaker of the house, and the senate president which programs in their respective departments were funded using monies from the opioid stewardship fund and the total amount of funds spent on each program.History of Section.P.L. 2019, ch. 88, art. 13, § 17; P.L. 2021, ch. 162, art. 2, § 2, effective July 6, 2021.
RI Gen L § 21-28.10-9 (2021)
2021 Rhode Island General Laws|Title 21 - Food and Drugs|Chapter 21-28.10 - Opioid Stewardship Act|Section 21-28.10-9 - Penalties.

§ 21-28.10-9. Penalties.(a) The department may assess a civil penalty in an amount not to exceed one thousand dollars ($1,000) per day against any licensee that fails to comply with this chapter.(b) (1) In addition to any other civil penalty provided by law, where a licensee has failed to pay its market share in accordance with § 21-28.10-5, the department may also assess a penalty of no less than ten percent (10%) and no greater than three hundred percent (300%) of the market share due from such licensee.(2) In addition to any other criminal penalty provided by law, where a licensee has failed to pay its market share in accordance with § 21-28.10-5, the department may also assess a penalty of no less than ten percent (10%) and no greater than fifty percent (50%) of the market share due from such licensee.History of Section.P.L. 2019, ch. 88, art. 13, § 17.